drugset / Trial / NCT01787994
Redirected MazF-CD4 Autologous T Cells for HIV Gene Therapy
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is an open label, dual cohort study evaluating safety, tolerability and immunogenicity of redirected CD4+ T cells in HIV subjects.
Timeline
- Start
- 2012-12
- Primary completion
- 2017-07
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MazF-T | Cell therapy | — | Intravenous |